v3.22.2.2
Summary of Significant Accounting Policies (Details) - USD ($)
12 Months Ended
Mar. 07, 2022
Oct. 15, 2020
Sep. 03, 2019
Feb. 06, 2019
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2022
Aug. 31, 2022
Aug. 18, 2022
Dec. 31, 2021
Summary of Significant Accounting Policies (Details) [Line Items]                    
Preferred stock authorized (in Shares)         200,000,000 200,000,000        
Common stock authorized (in Shares)         4,000,000,000          
Perferred stock par value (in Dollars per share)         $ 0.0001          
Common stock par value (in Dollars per share)         $ 0.0001          
Acquired stock percentage     100.00%              
Purchase price of common shares     $ 1,350,000              
Note payable to seller     $ 3,000,000              
Payment of secured percentage   50.00%                
Assets acquired   $ 120,000                
Promissory note   $ 44,526                
Issuance of shares (in Shares)   10,000,000                
Product sales percentage         90.00%          
Sale of common shares (in Shares)       193            
Security tax deposited percentage             50.00%     50.00%
Deferred deposits and payment due         $ 457,704          
Employee credits         $ 40,000 $ 40,000        
Reserve split 200:1                  
Common shares reserved (in Shares)         34,952,209          
Restricted common shares issued (in Shares)         2,437,467          
Product warranty claims         $ 108,043 108,043        
Warranty expense         $ 8,900 $ 5,693        
Initial contract         2 years          
Units percentage           11.00%        
Recognized revenue         $ 1,171,344 $ 1,467,589        
Allowance for doubtful accounts                
Accounts receivable - unbilled         175,436 190,779        
Inventory reserves         116,362 67,635        
Depreciation expense         35,474 16,005        
Asset required to goodwill         834,220          
Impaired intangible assets         37,885          
Inventory         193,346          
Estimated amortization expense related to intangible assets 2023         370,344          
Estimated amortization expense related to intangible assets 2024         168,367          
Estimated amortization expense related to intangible assets 2023         131,510          
Amortization expense         254,245 474,635        
Amortization of product development costs         271,062 195,996        
Estimated amortization expense related to intangible assets 2024         65,724          
Estimated amortization expense related to intangible assets 2025         50,635          
Estimated amortization expense related to intangible assets thereafter         24,512          
Research and development costs         $ 0 0        
Supplier Agreement [Member]                    
Summary of Significant Accounting Policies (Details) [Line Items]                    
Initial contract         1 year          
Minimum [Member]                    
Summary of Significant Accounting Policies (Details) [Line Items]                    
Straight-line basis period         2 years          
Maximum [Member]                    
Summary of Significant Accounting Policies (Details) [Line Items]                    
Straight-line basis period         5 years          
Other Intangible Assets [Member]                    
Summary of Significant Accounting Policies (Details) [Line Items]                    
Estimated amortization expense related to intangible assets 2023         $ 272,000          
Estimated amortization expense related to intangible assets 2024         272,000          
Estimated amortization expense related to intangible assets 2023         $ 88,099          
Other Intangible Assets [Member] | Minimum [Member]                    
Summary of Significant Accounting Policies (Details) [Line Items]                    
Straight-line basis period         3 years          
Other Intangible Assets [Member] | Maximum [Member]                    
Summary of Significant Accounting Policies (Details) [Line Items]                    
Straight-line basis period         6 years          
Forecast [Member]                    
Summary of Significant Accounting Policies (Details) [Line Items]                    
Note payable to seller               $ 900,000 $ 144,200  
Forecast [Member] | Minimum [Member]                    
Summary of Significant Accounting Policies (Details) [Line Items]                    
Common stock authorized (in Shares)               20,000,000    
Forecast [Member] | Maximum [Member]                    
Summary of Significant Accounting Policies (Details) [Line Items]                    
Common stock authorized (in Shares)               200,000,000    
Research and Development Expense [Member]                    
Summary of Significant Accounting Policies (Details) [Line Items]                    
Research and development costs         $ 503,706 $ 508,266